CANCER SUMMIT 2022
On April 14th and 15th, 2022, the 3rd International Conference on Cancer Science and Therapy will bring together a unique and international mix of specialists to discuss and share their experiences and research findings on all aspects of cancer research and therapies.
We invite scientists, researchers, engineers, academics and students, industry, investors, and people from all walks of life who are interested in Cancer Science Research to attend the conference and share their experiences and lessons learned with others, as well as explore opportunities for collaboration.
A thorough technical program encompassing the most recent research and innovation in cancer field will be presented at Cancer Summit 2022. Submission subjects of interest include, but are not limited to:
Track 01: Coronavirus (COVID 19) and Cancer
Track 02: Cancer Science: Current Concepts
Track 03: Organ-Defined Cancers
Track 04: Cancer Stem Cells & Bio-markers
Track 05: Cancer Immunology and Pathology
Track 06: Cancer Research with Robotics and AI
Track 07: Carcinogenesis & Mutagenesis
Track 08: Nanotechnology in Cancer Therapeutics
Track 09: Cancer Genomics and Oncology
Track 10: Cancer Genetics
Track 11: Breast Cancer
Track 12: Cancer Nursing & Palliative Care
Track 13: Gynaecological Cancers
Track 14: Cancer Pharmacology
Track 15: Radiology
Track 16: Cancer Prevention Vaccines
Track 17: Cancer Biology & Epidemiology
Track 18: Cancer Therapy & Treatments
Track 19: Chemotherapy
Track 20: Cancer Prevention & Control
Track 21: Cancer Biopsy
Track 22: Integrative & Computational Cancer Biology
Track 23: Nutrition in Cancer Care
Track 24: Clinical and Medical Oncology
Track 25: Virology and Oncology
Track 26: Head and Neck Cancer
Track 27: Cancer Clinical Trials
Cancer Summit 2022, presented by United Research Forum, uses a dynamic approach to event management to provide a unique platform for each section of participants to share their research and experiences. This International Conference has several important characteristics that make it worthwhile for CPD accreditations to attend.
To kick off the event, invited noble laureates and industry experts will discuss their vast expertise and important scientific breakthroughs in a Keynote Forum.
Plenary Talks: Over 30 speakers from prominent institutions and healthcare companies share their research and address the audience on all aspects of the topic.
Panel Discussion: Intermittent conversations and exchange of opinions in a panel of 4–5 people on a shared topic related to the subject to bring attention to the issue.
Networking: The conference gives sufficient chance to meet, greet, and talk even during off-hours, with a diverse group of young researchers to Nobel laureates.
Cancer conference includes spaces open during the two days for product and service-oriented firms to present themselves and build brand recognition, in addition to the exposition of expertise.
Corona Virus (COVID - 19) is a huge virus family that causes illnesses ranging from the common cold to more serious conditions including Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome. Coronavirus is a novel strain that has never been seen in people before. Coronavirus is a zoonotic illness that spreads from animals to humans.
Cancer is a word used to describe illnesses in which aberrant cells develop uncontrollably and can infect surrounding tissues. Cancer cells can potentially travel through the blood and lymph systems to other areas of the body.
Many areas of the body are affected by cancer, including the breasts, lungs, colon, brain, bones, and prostate.
According to the stem cell hypothesis of cancer, a small percentage of malignant cells behave like stem cells, reproducing and sustaining the disease in the same way that normal stem cells renew and support our organs and tissues.
Cancer biomarkers (CB) are biomolecules generated by tumor cells or other body cells in reaction to the tumor, and CB might be utilized as a cancer screening/early detection tool, diagnostic, prognostic, or predictive for a patient's ultimate result.
Cancer immunology is a branch of biology concerned with the function of the immune system in the formation and progression of cancer cells.
A pathology report is a medical document that details the diagnosis of illnesses such as cancer.
The use of AI and robotics to build a diagnosis technique will assist to minimise the frequency of late-stage cancer diagnoses. Better imaging, robotics, and artificial intelligence (AI) will all be used in the new multinational studies to identify cancer at an early stage. It also aspires to create whole new cancer detection techniques.
Carcinogenesis, also known as oncogenesis or tumorigenesis, is the process through which healthy cells change into cancerous cells. Changes at the cellular, genetic, and epigenetic levels, as well as aberrant cell division, characterize the process.
Mutagens create DNA alterations that can damage cells and cause illnesses like cancer.
Nanotechnology has the potential to identify cancer-related chemicals quickly and sensitively, allowing scientists to discover molecular alterations in a tiny fraction of cells. Nanotechnology has the ability to create completely new and extremely effective medicinal treatments.
Advances in sequencing technologies, computational approaches and tumor models, understanding of cancer processes, and the application of new methods to studying cancer are currently an exciting and fast-paced topic, with great promise for developing important breakthroughs in cancer treatment and prevention.
In roughly 5 to 10% of all malignancies, genetic alterations have a significant impact. More than 50 hereditary cancer syndromes have been linked to mutations in particular genes, which are diseases that may predispose people to various malignancies.
Breast cancer is more common in women than in males. A lump in the breast, bloody flow from the nipple, and changes in the form or texture of the nipple or breast are all signs of breast cancer. Its therapy is determined by cancer's stage. Chemotherapy, radiation, hormone treatment, and surgery may all be used.
An oncology nurse is a type of nurse that specialized in caring for cancer patients. These nurses require advanced qualifications and cancer clinical experience beyond what a standard baccalaureate nursing school may give.
Physical symptoms and side effects can occur as a result of cancer and its treatment. They can also have psychological, social, and economical consequences. Palliative care, also known as supportive care, is the treatment of these side effects.
Gynecologic oncology is a subspecialty of medicine that focuses on malignancies of the female reproductive system, such as ovarian, uterine, vaginal, cervical, and vulvar cancer.
Medicines are frequently used to treat leukemia and cancers of the breasts, ovaries, and intestines by doctors. 5-fluorouracil, 6-mercaptopurine, cytarabine, gemcitabine, and methotrexate are only a few of the drugs in this category.
Radiology techniques such as X-rays, CT scans, and other diagnostic imaging treatments are used to assist find, stage, and diagnose malignancies. Radiation therapy is a treatment that kills cancer cells and shrinks tumors by delivering high doses of focused radiation.
Vaccines are medications that aid the body's defense against illness. They can teach the immune system will detect and eliminate dangerous bacteria and cells. Cancer vaccinations are also available. Cancer vaccinations are used to both prevent and treat the disease.
Cancer epidemiology is the study of the variables that influence cancer. Cancer epidemiology is the study of using epidemiological approaches to determine the cause of cancer and to identify and create better therapies.
Some cancer patients will just require one therapy. Most patients, on the other hand, receive a mix of therapies, such as surgery combined with chemotherapy and/or radiation therapy. Immunotherapy, targeted therapy, and hormone therapy are examples of treatments. Clinical trials might be utilized to help people with cancer.